BLOG

Obesity Drugs

BioPharma Trends in the News – November 2025

Three recent BioPharma trends are making waves in the industry: breakthroughs in virus imaging for vaccine development, a new FDA pathway to accelerate rare disease treatments, and historic Medicare deals lowering costs for leading obesity and diabetes drugs. Here’s what’s shaping the latest in healthcare. Source: DDW.com Researchers have captured

READ MORE »
KOL ID Roundtable Panel

Roundtable Q&A: The Future of KOL/KEE ID and Mapping

The BioPharma world is a fast-evolving one, but Key Opinion Leaders (KOLs) and Key External Experts (KEEs) remain the core component of transforming awareness into action. What is KOL/KEE Identification and what are some scenarios in which it might be done? KOL/KEE Identification and mapping is pinpointing highly respected, distinguished,

READ MORE »
FDA Approval Stamp

BioPharma Trends in the News – October 2025

The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Reuters Several major pharmaceutical companies are responding to recent U.S. policy shifts by cutting drug prices and announcing plans to sell

READ MORE »
Magnifying glass identifying an expert

How to Identify Top Experts

Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.

READ MORE »
GLP-1 Administration

BioPharma Trends in the News – September 2025

The BioPharma industry is in rapid flux, shaped by rising tariffs, shifting policies, and new barriers to prescription access. Here’s a quick look at the forces driving change. Source: Time.com The time is now to review your campaigns as FDA oversight ramps up after years of minimal enforcement. Trump’s executive

READ MORE »